Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness
Authors:
Open Access
- 8 October 2021
- journal article
- other
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 21 (7) , 899-907
Abstract
Despite high vaccination coverage among children and adolescents, pertussis remains a public health problem, with large outbreaks occurring periodically in the US and other developed countries.We e...Keywords
Funding Information
- funded
This publication has 103 references indexed in Scilit:
- Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in ChildrenNew England Journal of Medicine, 2012
- Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable DiseaseNew England Journal of Medicine, 2012
- Middle School Vaccination Requirements and Adolescent Vaccination CoveragePediatrics, 2012
- Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis InfectionClinical Infectious Diseases, 2011
- Transmission of Bordetella pertussis to Young InfantsThe Pediatric Infectious Disease Journal, 2007
- Encephalopathy After Whole-Cell Pertussis or Measles VaccinationThe Pediatric Infectious Disease Journal, 2006
- Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) VaccinePediatrics, 2006
- Societal Costs and Morbidity of Pertussis in Adolescents and AdultsClinical Infectious Diseases, 2004
- Long-Term Pertussis-Specific Immunity after Primary Vaccination with a Combined Diphtheria, Tetanus, Tricomponent Acellular Pertussis, and Hepatitis B Vaccine in Comparison with That after Natural InfectionInfection and Immunity, 2001
- DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPANThe Lancet, 1984